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Abstract
The biological function of the Prion protein remains largely unknown but recent data revealed its implication in early
zebrafish and mammalian embryogenesis. To gain further insight into its biological function, comparative transcriptomic
analysis between FVB/N and FVB/N Prnp knockout mice was performed at early embryonic stages. RNAseq analysis revealed
the differential expression of 73 and 263 genes at E6.5 and E7.5, respectively. The related metabolic pathways identified in
this analysis partially overlap with those described in PrP1 and PrP2 knockdown zebrafish embryos and prion-infected
mammalian brains and emphasize a potentially important role for the PrP family genes in early developmental processes.
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Introduction
The Prion protein, PrP, has been the focus of intensive research
for decades due to its pivotal role in transmissible spongiform
encephalopathies, a group of infectious neurodegenerative diseases
of animal and human characterized by the accumulation of a
pathological form of the protein (PrP
Sc) [1–3]. The physiological
function of this ubiquitously expressed protein is still unclear.
Various roles in neuroprotection, cellular homeostasis, response to
oxidative stress, cell proliferation and differentiation, synaptic
function and signal transduction have been proposed [4–7]. Even
the sub-cellular localization of this glycosyl-phosphatidyl-inositol-
anchored cell surface glycoprotein remains a subject of debate
leading to yet other purported physiological processes involving
PrP ([8] for exemple). The difficulty to define a role for this protein
partially comes from the observation that Prnp-knockout mice
[9,10], cattle [11] and goat [12] suffer from no drastic
developmental phenotype. Similarly, invalidation of this gene in
adult mouse neurons does not affect the overall health of the mice
[13,14]. It has been hypothesized that another host-encoded
protein is able to compensate for the lack of PrP [15] or, if not
redundant, that PrP has no physiological function [16].
Comparative transcriptomic and proteomic analyses of adult
brain from Prnp-knockout mice did not reveal drastic alterations if
any [17,18], supporting the above-mentioned hypothesis. A recent
transcriptomic study performed on the hippocampus of wild-type
and Prnp
2/2 new born (4–5 day-old) and adult (3 month-old)
mice, revealed only a moderate alteration of the gene expression
profile [19]. On the other hand, developmental regulation of the
mouse Prnp gene suggested possible involvement of PrP in
embryogenesis [20–23]. Its implication in hematopoietic [24,25],
mesenchymal [26], neural [27], cardiomyogenic [28] and
embryonic [29,30] stem cell proliferation, self-renewal and
differentiation was also recently highlighted.
In zebrafish, the Prnp gene is duplicated and encodes proteins
PrP1 or PrP2. PrP1 or PrP2 loss-of-function were found to be
detrimental to zebrafish embryogenesis and survival [31–33].
Furthermore we found in a previous study that PrP and its paralog
Shadoo are required for early mouse embryogenesis as embryonic
lethality was observed at E10.5 in Sprn-knockdown, Prnp-knockout
embryos [34].
Altogether, these data suggest that even though PrP knockout is
not lethal, the physiological role of PrP may have to be
investigated at early developmental stages rather than in adults,
or in specific cell types such as adult stem cells. The aim of this
study is to assess the potential transcriptomic incidence of Prnp-
gene invalidation at early embryonic stages (6.5 and 7.5 dpc.).
Results and Discussion
Prnp-invalidation induces transcriptomic alterations at
E6.5 and E7.5
Pools of FVB/N and FVB/N Prnp-knockout embryos were
collected at E6.5 and E7.5 and their RNAs analyzed by RNAseq.
These two developmental time-points were chosen according to
the previously observed lethality in FVB/N Prnp-knockout, Sprn-
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substantial at E8.5, the gastrulation stage in mouse (BP and MV
unpublished data). Seventy-three and 263 differentially expressed
genes were detected between the two genotypes studied at E6.5
and E7.5, respectively (Table 1 and S2), representing 0.23 and
0.78% of total expressed genes. The majority of differentially
regulated genes were under-expressed in Prnp-knockout versus
wild-type embryos, 71.2 and 89.7% at E6.5 and E7.5, respectively
(Table 1).
To be pointed out, the Prnp mRNA itself was not significantly
differentially expressed at either E6.5 or E7.5. This observation is
explained by the fact that the knocking out was performed by
insertion of a neomycin-resistance gene within exon 3 of the Prnp
locus [9]. The Prnp gene remains transcribed, although at an
approximately 2-fold lower level as observed by Northern blotting
and according to the RNAseq data (data not shown), but the
resulting mRNA no longer encodes for PrP [9].
Ten genes were arbitrarily chosen for confirmation by RT-
PCR. This was performed on E7.5 RNA samples different from
those used for RNAseq experiments. The amplification signals
obtained for the Ptrf and Prss28 transcripts were too low to be
analyzed (data not shown). The RT-PCR analyses of the
remaining 8 genes were congruent with the results obtained by
RNAseq (Figure 1 and Table S2), confirming that comparative
RNAseq analysis is a quantitative approach [35].
Twelve genes were differentially expressed at both embryonic
stages of which 5 were consistently over-expressed in Prnp-
knockout embryos (Table 2). Of note, these 5 genes, Prss28,
Prss29, Napsa, MmP7 and XM_001477507.1, a transcript similar
to that of ISP-2, share proteolysis activities and can modulate
cellular adhesion and extracellular matrix deposition [36].
In silico analysis of the pathways affected by the observed
transcriptomic alterations was undertaken to gain new insight into
the biological function of PrP during mouse embryogenesis.
Convergence of Prnp-invalidation induced transcriptomic
alterations between mouse and Danio rerio embryos
As mentioned above, 5 of the 12 genes that were differentially
expressed at E6.5 and E7.5 were over-expressed in Prnp-knockout
embryos and encode endopeptidases (Tables 2, 3 and S2). Mmp7
deregulation could be a consequence of the up-regulation of the
Pax8 transcription factor at E6.5, as suggested by GEPS analysis
(Figure 2), although to our knowledge a direct functional link
Table 1. Number of differentially expressed genes in Prnp-invalidated mouse embryos.
E6.5 E7.5
Total number of Differentially
expressed genes
73 263
Up-regulated 21 (28,76%) 27 (10.2%)
.10 fold 4 (5.47% of deregulated genes, 19.04% of
up-regulated) LOC676933, Pax8, Mgat4c, Ptrf
7 (2.66% of deregulated genes, 25.92%
of up-regulated) Serpina1e, Napsa, Prss28,
Prss29, NM_024283.2, Slco1a6, Prap1
Down-regulated 52 (71.23%) 236 (89.7%)
.10 fold 29 (39.72% of deregulated genes, 55.76% of
down-regulated) Speer2, Fam186b, Rax, H2-M10.1,
LOC633979, Magel2, LOC100046045, Cdh22, Myoz1,
LOC100043825, Rmrp, Indol1, Scrt2, NM_175674.2,
Dnajb5, Pcdh19, Mib2, LOC100046008, Scn3b, Rufy3,
Stac3, Fam154b, EG666182, LOC633979, Hist4h4,
Chsy3, XM_130735.7, LOC435145, Hmx2
47 (17.87% of deregulated genes, 19.91% of
down-regulated) NM_177599.3, Msln, Hspb7, Kcnd3,
Slpi, Tnfaip3, SecTm1b, Cst9, XM_001478533.1, Samd12,
XR_032778.1, Corin, Havcr2, Ppp1r3c, Cyp2j11, Lsamp,
Hsd11b1, Slc6a12, Lyve1, Ugt1a1, Cldn1, Emcn, Gpr115,
Klk14, XR_034037.1, Anxa8, Psca, Lims2, Ly6Cc1,
Ugt1a6b, Ly6c2, misc, Ly-6c, Pdzk1ip1, Tmem154, Ly6A,
Tnfrsf11b, Gpr64, Lbp,Gpr115, Pglyrp1, Angpt4, Des,
Tdo2, NM_172777.2, Dmkn, Alox5,
Genes deregulated more than 10 fold are listed.
doi:10.1371/journal.pone.0023253.t001
Figure 1. PCR analysis of differentially expressed genes. Gel
electrophoresis showing the amplification signals obtained by RT-PCR
for 8 genes identified by RNAseq as being differentially expressed. The
RT-PCR analyses of these 8 genes were congruent with the results
obtained by RNAseq. Beta-actin was used as an internal control. PrP +
and 2: pools of E7.5 FVB/N and FVB.N Prnp-knockout embryo RNAs,
respectively.
doi:10.1371/journal.pone.0023253.g001
Table 2. Genes differentially expressed at both E7.5 and E6.5.
Name E7.5 (WT versus KO) E6.5 (WT versus KO)
Ptrf 0.120 13.726
Rmrp 4.18 9.153
Napsa 26.437 9.153
4933425M15 6.025 0.062
Prss28 16.875 5.26
Prss29 16.687 9.117
Mib2 5.011 0.067
LOC100047285 9 9.477
Acvr1c 3.401 0.181
Mmp7 7.781 6.44
Rpph1 3.087 0.114
LOC677333 2.452 0.186
Numbers refer to fold change.
doi:10.1371/journal.pone.0023253.t002
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tidases can modulate the biological levels of cadherins and catenins
and it was hypothesized that such induced alterations in cell-cell
communication were at the origin of the arrested gastrulation
observed in PrP1-depleted zebrafish embryos [31]. At E6.5,
cadherin 22 and protocadherin 19 were indeed down-regulated in
Prnp-knockout mouse embryos, suggesting an induced perturba-
tion of cell movement [37], as described in zebrafish. Moreover, a
correlation between lack of PrP and down-regulation of cadherins
was recently described in the mouse hippocampus [19]. Modified
cellular adhesion and cell proliferation pathways were detected at
E7.5 (Table 3) [36,38]. These networks highlight potential key
regulatory roles of the growth factor Fgf5, Igf1 and Tdgf1 proteins,
expression of which was significantly modified in the absence of
PrP (Supplementary data Table S2 and data not shown).
Biological links between some of these proteins and PrPc have
already being described in adult tissues [39–41]. However, their
modified expression could be indirectly linked to that of PrP, and
induced by overexpression of Pou5f1 (Figure 3). This transcription
factor is up-regulated in Prnp-knockout E7.5 embryos (Table S2)
and has been associated with FGF5 and TDFG1 gene regulation
[42,43]. Expression of Pou5f1 and PrP was recently found to be
correlated in differentiating mouse ES cells [30]. The Igf1
deregulation might be a consequence of the observed deregulation
of Wt1 ([44] and Table S2), although the link between the Wt1
transcription factor and Igf1 regulation remains hypothetical. On
the other hand, the up-regulation of Fgf5 could have in turn down-
regulated that of Igf1 in the absence of PrP, as already observed
[39]. Thus, the Prnp-knockout induced deregulation of Pou5f1
might be the trouble spot at the origin of these networks (Figure 3).
At E7.5, the relative over-expression levels of Prss28, Prss29,
Napsa, MmP7 and XM_001477507.1 in Prnp-knockout embryos
were significantly elevated compared to those observed at E6.5
(Table 2 and S2). Protease inhibitors such as Slpi, Cst9, A2m were
also down regulated at this stage, which could increase the activity
Figure 2. Differentially expressed gene pathway at E6.5 linking
Pax8 and Mmp7. A pathway was generated by the GEPS program
from Genomatix that connects differentially expressed genes found at
E6.5. It suggests a modulation of the matrix metalloprotease Mmp7 by
PAX8. (See Figure S2 for detailed Genomatix network legend).
doi:10.1371/journal.pone.0023253.g002
Table 3. Summary of the highest represented functional groups of genes from the differentially expressed gene list at E7.5.
Category Genes
Nb of
genes
Proteolysis Prss28,Prss29,Napsa,Mmp7,XM_001477507.1(similar to ISP-2),Ctsk,Ctso 7
Protease inhibition Slpi,Cst9,A2m,Serpina1e 4
Biological adhesion Igfbp7,Angpt2,Smoc2,Epdr1,Sned1,Igsf11,Nrcam,Lsamp,Thy1,Adam12,Cd36,
Cd34,Lamb2,Gpnmb,Tdgf1,Fbln2,Msln,Lyve1,Cldn1,Cldn5
20
Nervous system
development
Igf1,Fgf5,Bdnf,Apob,Aqp1,Sgk1,Bmp2,Atoh8,Tgfbr2,Cldn5,Cldn1,Gja1,Thy1,
Eomes,Ednrb,Mt3,Tacc1,Hoxd10,Hdac9,Nrcam,Corin,Mal,Lamb2
23
Apoptosis Tnfrsf11b,Igf1,Bdnf,Ednrb,Bmp2,Irak3,Tlr4,Pglyrp1,Pmaip1,Casp12,Tnfaip3, Gja1,Sgk1,Wt1,Srgn,Acvr1c,Anxa1,Cryab,Cryaa,Mal 20
Cell proliferation Fgf5,Igf1,Bdnf,Ednrb,Lgr4,Tgfbr2,Tlr4,Ptges,Acvr1c,Fosl2;Bmp2 Ptgs1,Gja1,Mmp7,Nampt,Sat1,Anxa1,Pmaip1,Tdgf1,Tacc1 20
Inflammatory and innate
immune response
Tlr4,Serping1,Cd55,Bmp2,Tlr3,Lbp,Alox5,Ggt5,Anxa1,Hdac9,Cd36,Pglyrp1,Irak3 13
Heart formation and blood
vessel development
Apob,Cd36,Igf1,Wt1,Angpt2,Tgfbr2,Gja1,Tdgf1,Thy1,Cdx4,Tnfaip2 11
Vascular diseases Atp8b1,Ugt1a1,Slco1a6,Rgs5,Tnfaip2,Rgs2,Nrcam,Pmaip1,Lsamp,Pou5f1,Mixl,
Tdgf1,Casp12,Lbp,Havcr2,Tlr4,Irak3,Tlr3,Fstl1,Add3,Ptn,Fgf5,Penk,Mt3,Bdnf,
Tgfbr2,Fbln2,Fbn1,Mfap5,Col5a2,Dcn,Lum,Ramp3,Sparcl1,Timp3,Ednrb,Gpx3,
Adam12,Abp1,Mgp,Bmp2,Fosl2,Vsig2,Cyp11b1,Igfbp7,Nampt,Sat1,Angpt2,Slpi,
Igf1,Alox5,Anxa1,S100a4,Pglyrp1,Ptgs1,Ptges,Tnfaip3,Hdac9,Hsd11b1,Slc2a12,Srgn,
Apob,Vldlr,Cd36,Tnfrsf11b,Ctsk,Cxcl14,Sgk1,Srd5a1,Bche,Gda,Abat,A2m,Gja1,Des,Dtna,
Cryab,Cd34,Il6ra,Abcd1,Hoxa10,Sfrp4,Sfrp5,Dkk2,Wt1,Tacc1,Cldn1,Cldn10a,Cldn5,
Lyve1,Emcn,Thy1,Cd55,Aqp1,Serping1,Ly6a,Ly6c1,Ly6c2,Gpihbp1
99
Response to oxidative
stress
Gpx3,Tlr4,Ptgs1,Anxa1,Cryab,Cryaa 6
Matrix metalloproteinase Angpt2,Slpi,Igf1,Timp3,Tlr4,Rgs2,Irak3,Ptges,Alox5,S100a4,Adam12,Mmp7,
Aqp1,Nampt,Wt1,Hoxa11,Bmp2,Tgfbr2,Bdnf,Fosl2,Jam2,Cldn5,Tnfrsf11b
23
Prion disease Bdnf,Igf1,Dcn,Bche,Tgfbr2,Srgn,Aqp1,Cd34,Thy1,Ly6a,Cryab,Anxa1,Ptgs1, Alox5,Tlr3,Tlr4,Casp12,Mt3 18
UP-regulated genes are in bold type.
doi:10.1371/journal.pone.0023253.t003
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was highly elevated. However, Pax8 up-regulation was not in
evidence at E7.5, neither were cadherin 22 and protocadherin 19
down-regulations, which might reflect an adaptation of the
embryonic metabolism.
Overall, this transcriptomic analysis reveals a striking biological
convergence between the PrP-knockout induced deregulation in early
mouse embryos and that previously described in PrP1-invalidated
zebrafish eggs [31]. The resulting outcome is not lethal in the mouse
which, according to the results published by us [34], suggests a
sufficient compensatory mechanism by the related Shadoo protein to
the absence of PrP that sustains the embryonic development. So far,
the developmental regulation of the Sprn gene and the biological
properties of the protein have not yet been described in zebrafish.
Such investigations could indirectly validate this hypothesis.
Invalidation of the later developmentally regulated PrP2-
encoding zebrafish gene led to impaired brain and neuronal
development [32]. Although it is reminiscent of the phenotype
observed in the surviving mouse Prnp-knockout, Sprn-knockdown
embryos [34], such phenotype has not been described for
mammalian Prnp-knockout embryos. However, our transcriptomic
analysis also highlights alterations of specific networks involved in
nervous system development in the Prnp-knockout mouse embryos,
as described below.
The transcriptomic alteration in Prnp-invalidated mouse
embryos evokes a negative image of that found in prion-
diseased brains
Although prion-associated pathologies have been extensively
studied, with detailed descriptions of the associated neuropathol-
ogy, the underlying mechanism leading to neurodegeneration is
still poorly understood ([47] for review). Among the existing
debate is the question whether this pathology results from a PrP
loss-of-function, a PrP
sc gain-of-function, a subversion of PrP
function by PrP
SC or a combination of these three mechanisms
[48]. The simple PrP loss-of-function hypothesis was not sustained
by the observation of the limited and subtle phenotypes resulting
from the gene invalidation in mammals [9–12].
Differentially expressed genes in prion-infected adult mouse
brains have been identified by microarray analyses [49–51].
Although strain-specific responses were detected leading to some
gene specificity, overall similar biological functions were high-
lighted in all experiments, such as cell growth and adhesion,
proteolysis, protease inhibition, response to oxidative stress,
inflammation, immune response, cell death and neurological
disorders. In each of the identified pathways, genes that were also
differentially expressed in our study were described. Indeed,
similar biological networks were identified by Ingenuity and
Genomatix analyses (Table 3). We have already mentioned
specific pathways involving cell proliferation and adhesion as well
as differentially expressed proteases and anti-proteases that
distinguish Prnp-knockout embryos from their wild-type counter-
parts (Table 3). At E7.5, matrix metalloprotease, apoptosis,
inflammatory response and response to oxidative stress networks
were also revealed by in silico analyses. Two genes appear to be
central to these networks, Igf1 and Tlr4 (Figure S1). As mentioned
previously, deregulation of Igf1 has previously been observed in
relation with PrP [39]. Invalidation of Tlr4 resulted in accelerated
prion disease pathogenesis in transgenic mice [52], a result
attributed to a modulation of the innate immune system response.
Our data would suggest that PrP expression per se has a role in
immune function in the absence of pathogenic prion.
Most of the differentially expressed genes were reported to be
up-regulated in prion affected adult brains while they are down-
regulated in Prnp-knockout embryos. For example, the up-
regulation of Cathepsins, a family of lysosomal proteases, has
been associated with neurodegenerative diseases, including
Alzheimer’s and prion diseases [49]. In contrast, our results
demonstrate a down-regulation of Cathepsins in the absence of
PrP. Overall; this observation suggests that the prion disease
pathology does not mimic a PrP-lack of function. On the contrary,
it seems that in the presence of infectious prions, the activated
cellular or tissue response is a negative of that observed in the
absence of PrP, suggesting that prions over-activate the normal
PrP protein signaling, leading to neurotoxicity. This hypothesis
may also relate to the observed down-regulation of the Shadoo
protein in terminally prion-affected mouse brains. In zebrafish,
this mirror effect would lead to embryonic lethality in the absence
of either PrP1 or PrP2, while in mammals, a host-encoded protein,
probably Shadoo [34], might allow for sufficient compensatory
Figure 3. Pou5f1 could modulate expression of other observed
key factors at E7.5. A GEPS network connecting the up-regulated
genes at E7.5 was detected. It shows a potential regulation by Pou5f1 of
the over-expressed key regulatory factors. (see Figure S2 for detailed
genomatix network legend).
doi:10.1371/journal.pone.0023253.g003
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(Figure 4).
Prnp-invalidation induced transcriptomic alterations are
consistent with a putative role of PrP during early
embryogenesis
Invalidation of PrP induces transcriptomic alterations that can
be related to several developmental processes. At E6.5, deregu-
lation of transcription and chromatin-related biological process
were detected, as exemplified by the down-regulation of various
histone cluster genes in Prnp-knockout embryos (Table S2),
possibly reflecting the above-mentioned perturbation of the cell
proliferation process. It further highlighted the implication of PrP
in the self-renewal and differentiation of stem cells [27,29,30].
Similarly, specific networks related to the development of the
nervous system were detected (Table 3), further emphasizing the
neuro-specificity of PrP signaling [7], as well as with other
developmental processes such as odontoblastic/osteogenic and
muscle development.
Our analysis pointed towards a major pathway involved in
cardiovascular development, hematopoiesis and angiogenesis, with
the identification of specific networks including vascular diseases,
arteriosclerosis, blood vessel development and morphogenesis
(Table 3 and data not shown). PrP has recently been shown to
identify bipotential cardiomyogenic progenitors [28] and to be
involved in the self-renewal of hematopoietic stem cells [24]. Its
absence in Prnp-knockout embryos negatively affects the expression
of Mesp1 (Supplementary data Table S2), a gene associated with
the earliest signs of cardiovascular development [53], potentially
capable of generating the multipotent cardiovascular progenitors
and involved in the epithelial-mesenchymal transition [54]. Prnp-
knockout embryos also had reduced expression of Timp-3, a gene
that expands the multipotent hematopoietic progenitor pool [55],
and that of Hoxa10, a gene also involved in this process [25]. Prnp
invalidation increased the expression of the MixL1 transcription
factor, capable of suppressing hematopoietic mesoderm formation
and promoting endoderm formation [56], and that of TDGF1 that
inhibits cell differentiation [57] (Figure 3). Finally, the absence of
PrP also negatively affects the expression of various G protein-
coupled receptors and doing so angiogenesis [58].
These findings raise the question if and to what extent PrP is
expressed in the cardiovascular system of the early embryo.
Immunochemistry analysis could not be performed at E7.5 for
technical reasons (see materials and methods). At E9.5, however, it
revealed expression of PrP in the developing heart, as previously
described using PrP-LacZ transgenic mice [22], with a particularly
intense signal in the region of the sinus venosus, a part of the
embryonic cardiovascular system draining the blood flow into the
heart (the venous pole) (Figure 5). Interestingly, expression pattern
of PrP in this region is reminiscent of that of Islet1, a transcription
factor gene expressed by cardiogenic progenitors [59]. In addition,
PrP expression was detected in the endothelium of blood vessels
such as the dorsal aortas. Worthy of note, PrP expression in the
cardiovascular system was of comparable intensity to that visible in
the nervous system, especially the developing neural tube
(Figure 5).
Expression of PrP in extra-embryonic tissue has been described
and occurs at early developmental stages [22,23,60]. The
transcriptomic perturbations observed in the Prnp-knockout
embryos affect genes involved in placentation. Adam12, a
candidate regulator in trophoblast fusion [61], is under-expressed
as well as the Cysteine-Cathepsins which are essential for extra-
Figure 4. Schematic presentation of the mirror effect hypothesis. The activated cellular and/or tissue response in the presence of PrPSc (right
side) is a negative image of that observed in the absence of PrP (left side). It suggests a mechanism of prion disease associated neurodegeneration in
which the over activation or subversion (Harris and True, 2006) of PrP by PrPSc could lead to neurotoxicity. In Prnp knockout mice, the presence of
the protein shadoo seems to be essential for an efficient compensatory mechanism and survival. In Prnp-knockout, Sprn-knockdown mice, an
embryonic lethality was observed, this lethality could be caused by a gastrulation defect characterized by placentation and hematopoesis defaults.
doi:10.1371/journal.pone.0023253.g004
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tially expressed (Table S2). Activin promotes differentiation of
mouse trophoblast stem cells [63] and its receptor controls
trophoblastic cell proliferation [64]. Differential expression of
other key regulators acting on placentation was observed such as
that of fibroblast growth factors [65], brain-derived neurotropic
factors [66] and proteins involved in the epithelial-mesenchymal
transition, Pou5f1, TDGF1, Mesp1 [54,67] and potentially Pax8
[68] (Table 3).
Overall, our analysis suggests that, through the deregulation of
the above-mentioned transcription factors and key genes involved
in the maintenance, renewal and differentiation of stem cells, PrP
invalidation affects numerous developmental processes that take
place around gastrulation. A biological effect of these deregula-
tions is a perturbation of the cellular interaction and cell
homeostasis. In zebrafish, it leads to a morbid phenotype. In
mammals, compensatory mechanisms would reduce this pheno-
type and allow sustaining a nearly normal embryonic develop-
ment. Recent data suggest that the prion-related Shadoo protein
has a crucial role in this process in the absence of PrP [34]. The
phenotype associated with the Prnp-knockout, Sprn-knockdown
genotype was not clearly identified but our current data support
the hypothesis of a lethal defect in early gastrulation in the absence
of these prion-related proteins characterized by a default in
placentation, angiogenesis and hematopoiesis (Figure 4). Current
investigations are underway to assess this hypothesis.
Materials and Methods
Animal experiments were carried out in strict accordance with
the recommendations in the guidelines of the Code for Methods
and Welfare Considerations in Behavioural Research with
Animals (Directive 86/609EC). And all efforts were made to
minimize suffering. Experiments were approved by the Committee
on the Ethics of Animal Experiments of the author’s institution,
INRA (Permit Number RTA06-091). All animal manipulations
were done according to the recommendations of the French
Commission de Ge ´nie Ge ´ne ´tique (Permit Number Nu12931
(01.16.2003)). Total RNA was isolated from pools of whole
FVB/N and FVB/N Prnp
2/2 mouse embryos at stages E6.5 and
E7.5 [9,69]. RNA extractions were performed using the RNeasy
Lipid Tissue Mini kit (Qiagen cat # 75842). RNA concentration
was calculated by electro-spectrophotometry and the RNA
integrity checked with the Agilent Bioanalyser (Waldbroom,
Germany).
RNA samples of 5 microg, obtained from around 30 embryos
each collected from 3 to 4 females, were sent to GATC Biotech
SARL for RNAseq analysis. A standard cDNA library was
derived from each sample, with colligation and nebulization of
cDNA and adapter ligation. These cDNAs were analyzed on an
Illumina Genome Analyzer II with raw data output of up to
350 Mb and 42,000,000 reads per sample and a read length of 36
bases (single read). Sequence cleaning was done using Seqclean
(http://compbio.dfci.harvard.edu/tgi/sofware/seqclean_README).
Cleaned reads were mapped to the NCBI mouse transcript database
(ftp://ftp.ncbi.nih.gov/genomed/M_musculus/RNA/) using BWA
software [70].
Differentially expressed genes between FVB/N and FVB/N
Prnp
2/2 embryos were identified at 5% FDR using the DESeq
software from the package R [71]. They were clustered using the
software DAVID [72,73], then classified in pathways by using
Ingenuity (http://www.ingenuity.com/) and in networks and
biological functions using the GEPS application of Genomatix
(http://www.genomatix.de).
RT-PCR analyses were performed using 3 microg of purified
RNA reverse transcribed with the SuperScript II Reverse
Transcriptase kit (Invitrogen), according to the manufacturer’s
protocol. RT-PCR analyses were performed using a set of
oligonucleotides located in different exons (Table S1) for each
gene analyzed to avoid potential genomic DNA amplification. The
Figure 5. Expression of PrP in the embryo. At E9.5, PrP expression
was observed in endothelial cells of blood vessels (a), including dorsal
aortas (b, c) and in the developing heart with, as shown in this figure, a
very intense signal observed in the sinus venosus. The saturated signal
visible here (asterisk) is artefactual. HSV: horn of the sinus venosus. At
E9.5, PrP expression in the nervous system is mainly detected in the
lateral part of the neural tube (NT), the mantle zone (arrow): this zone is
formed by cells undergoing differentiation that have migrated from the
medial part of the neural tube where cells continue to divide
(progressively during development, PrP staining in neural tube
increases as the mantle zone thickened; our unpublished data).
doi:10.1371/journal.pone.0023253.g005
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30 s and 72uC for 40 s. Amplified fragments were visualized under
UV following size resolution by 1.5% agarose gel electrophoresis
in the presence of ethidium bromide.
For immunohistochemistry, transverse sections of E9.5 FVB/N
formalin-fixed embryos (14 microm-thick) were stained with
Sha31 antibody [74]. Images were acquired using a Zeiss
microscope. E9.5 FVB/N Prnp
2/2 embryos were used as negative
controls. It should be noted that immunohistochemistry analysis
performed on younger embryos led to an artefactual signal, thus
preventing the study of expression of PrP at earlier stages.
Supporting Information
Figure S1 A network connecting the differentially
expressed genes at E7.5. A network connecting the differen-
tially expressed genes from Prnp Knock-out embryos was identified
by GEPS application from Genomatix in which Tlr4 and Igf1
occupy a central role alongside, but to a lesser extent, Cd34 and
Thy1. Red color indicates up- and blue down-regulated genes,
respectively (see supplementary data Figure 2 for detailed
Genomatix network legend).
(TIF)
Figure S2 Genomatix pathway system legend. Descrip-
tion of the genomatix pathway system legend is given. It applies to
the figures 2 and 3.
(TIF)
Table S1 Primer sets used for PCRs.
(DOCX)
Table S2 List of differentially expressed genes in Prnp-
knockout embryos. Up-regulated genes are in green. Down-
regulated genes are in red.
(DOCX)
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